JP Morgan Chase
MBOT icon

JP Morgan Chase’s Microbot Medical MBOT Stock Holding History

JP Morgan Chase’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$789 Buy
+422
New +$860 ﹤0.01% 7364
2025
Q1 		– Sell
-38
Closed -$43 – 7570
2024
Q4 		$43 Buy
+38
New +$37 ﹤0.01% 7160
2024
Q3 		– Sell
-186
Closed -$190 – 7568
2024
Q2 		$190 Sell
186
-995
-84% -$1.02K ﹤0.01% 6796
2024
Q1 		$1.45K Buy
1,181
+11
+0.9% +$14 ﹤0.01% 6612
2023
Q4 		$1.92K Buy
1,170
+7
+0.6% +$9 ﹤0.01% 6728
2023
Q3 		$1.62K Buy
+1,163
New +$2.52K ﹤0.01% 6577
2021
Q3 		– Sell
-418
Closed -$3K – 6666
2021
Q2 		$3K Buy
+418
New +$3.16K ﹤0.01% 6179
2020
Q4 		– Sell
-4
Closed – – 5810
2020
Q3 		$0 Hold
4
– – ﹤0.01% 5648
2020
Q2 		$0 Buy
+4
New +$27 ﹤0.01% 5569
2019
Q3 		– Sell
-9,068
Closed -$45K – 5863
2019
Q2 		$45K Buy
+9,068
New +$60K ﹤0.01% 5208

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

JP Morgan Chase's MBOT Position: Q2 2026 in Review

JP Morgan Chase opened a new position in Microbot Medical (MBOT) in Q2 2026: 422 shares worth $789. The stake represents ﹤0.01% of the portfolio and ranks #7364 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in MBOT as recently as Q4 2024.

JP Morgan Chase first reported a position in MBOT in Q2 2019 and has held it in 10 quarters since. The position peaked at $45K in Q2 2019. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • JP Morgan Chase held 422 shares of Microbot Medical worth $789 as of Q2 2026.
  • Microbot Medical was a new JP Morgan Chase position in Q2 2026.
  • Microbot Medical made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7364 holding.
  • JP Morgan Chase first reported a position in Microbot Medical in Q2 2019 and has held it in 10 quarters since.
  • JP Morgan Chase's Microbot Medical position peaked at $45K in Q2 2019.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.